Indirubin suppresses ovarian cancer cell viabilities through the STAT3 signaling pathway

Lihong Chen(Fujian Medical University), Jifen Hu(Fujian Medical University)
Drug Design Development and Therapy
October 1, 2018
Cited by 41


Related Papers